| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Molecular Templates Inc (NASDAQ: MTEM)
MTEM Technical Analysis
5
| As on 20th Dec 2024 MTEM STOCK Price closed @ 0.16 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.83 & Strong Sell for SHORT-TERM with Stoploss of 4.61 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MTEMSTOCK Price
| Open | 0.15 | Change | Price | % |
| High | 0.18 | 1 Day | -0.19 | -54.29 |
| Low | 0.14 | 1 Week | -0.27 | -62.79 |
| Close | 0.16 | 1 Month | -0.23 | -58.97 |
| Volume | 8361441 | 1 Year | -0.31 | -65.96 |
| 52 Week High 9.14 | 52 Week Low 0.32 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| APTO | 0.28 | 64.71% |
| NVDA | 134.70 | 3.08% |
| TNXP | 0.61 | 7.02% |
| LCID | 3.02 | 14.83% |
| TAOP | 0.41 | 28.12% |
| AVGO | 220.79 | 1.13% |
| TSLA | 421.06 | -3.46% |
| QUBT | 17.62 | 16.38% |
| AAPL | 254.49 | 1.88% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| MTEM Daily Charts |
MTEM Intraday Charts |
Whats New @ Bazaartrend |
MTEM Free Analysis |
|
|
MTEM Important Levels Intraday
| RESISTANCE | 0.24 |
| RESISTANCE | 0.21 |
| RESISTANCE | 0.20 |
| RESISTANCE | 0.18 |
| SUPPORT | 0.14 |
| SUPPORT | 0.12 |
| SUPPORT | 0.11 |
| SUPPORT | 0.08 |
MTEM Forecast December 2024
| 4th UP Forecast | 16.75 |
| 3rd UP Forecast | 11.43 |
| 2nd UP Forecast | 8.14 |
| 1st UP Forecast | 4.85 |
| 1st DOWN Forecast | -4.53 |
| 2nd DOWN Forecast | -7.82 |
| 3rd DOWN Forecast | -11.11 |
| 4th DOWN Forecast | -16.43 |
MTEM Weekly Forecast
| 4th UP Forecast | 0.41 |
| 3rd UP Forecast | 0.33 |
| 2nd UP Forecast | 0.28 |
| 1st UP Forecast | 0.23 |
| 1st DOWN Forecast | 0.09 |
| 2nd DOWN Forecast | 0.04 |
| 3rd DOWN Forecast | -0.01 |
| 4th DOWN Forecast | -0.09 |
MTEM Forecast2024
| 4th UP Forecast | 17.52 |
| 3rd UP Forecast | 11.95 |
| 2nd UP Forecast | 8.51 |
| 1st UP Forecast | 5.07 |
| 1st DOWN Forecast | -4.75 |
| 2nd DOWN Forecast | -8.19 |
| 3rd DOWN Forecast | -11.63 |
| 4th DOWN Forecast | -17.2 |
Molecular Templates Inc ( NASDAQ USA Symbol : MTEM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MTEM Business Profile
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other diseases. Its proprietary drug platform technology is engineered toxin bodies (ETBs). The company's lead drug candidate is MT-3724 that is in a Phase II clinical trial for the treatment of relapsed and refractory diffuse large B-cell lymphoma; and Phase II clinical trial for treating non-Hodgkin's lymphoma. It also develops MT-4019, engineered toxin body targeting CD38; TAK-169 targeting CD38 is in Phase I clinical trial; MT-5111 targeting HER2 is in Phase I clinical trial; and MT-6402 with antigen seeding targeting PD-L1. The company has an agreement with Takeda Pharmaceutical Company Limited to develop CD38-targeted engineered toxin bodies for the treatment of patients with diseases, such as multiple myeloma; and a strategic research collaboration with Vertex Pharmaceuticals Incorporated to discover and develop novel targeted biologic therapies for applications outside of oncology; and Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. is headquartered in Austin, Texas. Address: 9301 Amberglen Boulevard, Austin, TX, United States, 78729
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service